期刊名称：AMERICAN JOURNAL OF CANCER RESEARCH
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Impact Factor 2013: 3.968
Published by e-Century Publishing Corporation
Journal information
The American Journal of Cancer Research (AJCR) (ISSN 2156-6976), is an independent open access, online only
journal to facilitate rapid dissemination of novel discoveries in basic science and treatment of cancer. It was
founded by a group of scientists for cancer research and clinical academic oncologists from around the world, who
are devoted to the promotion and advancement of our understanding of the cancer and its treatment.
The scope of AJCR is intended to encompass that of multi-disciplinary researchers from any scientific discipline
where the primary focus of the research is to increase and integrate knowledge about etiology and molecular
mechanisms of carcinogenesis with the ultimate aim of advancing the cure and prevention of this increasingly
devastating disease. To achieve these aims AJCR will publish review articles, original articles and new techniques
in cancer research and therapy. It will also publish hypothesis, case reports and letter to the editor.
Unlike most other open access online journals, AJCR will keep most of the traditional features of paper print
that we are all familiar with, such as continuous volume, issue numbers, as well as continuous page numbers to
retain our comfortable familiarity towards an academic journal.
AJCR will be officially launched in January, 2011, and published as a quarterly journal. Publication frequencies can
be increased to as bi-monthly or even monthly if more manuscripts are received. We are accepting manuscript
submissions at this time. All manuscripts will be peer reviewed and published within two weeks if accepted. If you
are interested in submitting a manuscript to AJCR for consideration of publication, please read the journal’s
Guidelines for Author and e-mail the manuscript to the Editorial Office at editorial@ajcr.us.
We are also inviting you to join the editorial board of AJCR. Please read the editorial board policy and then contact
us together with your updated CV, 5-10 keywords of your research interest, the weblink of your professional
webpage that is hosted in your affiliated university or institute if you are interested.
Indexed in: PubMed, PMC, Web of Knowledge (SCI) of Thompson Reuters (accepted),Google Scholar
Instructions to Authors
The American Journal of Cancer Research (AJCR, ISSN 2156-6976) is an independent open access online journal
dedicated to publication of original work in all areas of cancer research. AJCR is primarily devoted to original research
papers (Main Research Articles and Brief Communications), and will also publish traditional Review articles. The goal of
AJCR is to provide a forum for rapid dissemination of novel discoveries in basic and clinical studies of all human
malignancies.
SUBMISSION OF MANUSCRIPT (Click to submit your manuscript online)
General Policy
All manuscripts are submitted with the understanding that they have not been published elsewhere (except in the form of an
abstract or as part of a published lecture or thesis) and are not currently under consideration for publication by another
journal. It is the responsibility of the corresponding author to ensure that all authors have contributed to, read and approved
the final manuscript for submission. The authors should keep a copy of manuscript submitted in case of revision, rejection,
loss or damage. Receipt of manuscript will be acknowledged and a decision regarding acceptance made as soon as
possible. Accepted manuscripts may be subject to editorial revision without notice.
Peer Review Policy
All manuscripts are subject to peer review and are expected to meet the rigorous standards of academic excellence.
Authors should provide 4 potential peer reviewers with detailed contact information including e-mail address. Authors may
also nominate 2 peers that they request are not sent the article for peer review for conflicts of interest or other appropriate
reasons – in such instances some reasonable justification must be given. These should be experts in their field of study,
who will be able to provide an objective assessment of the manuscript. If not provided, potential reviewers will be identified
by their publication record or recommended by the Editorial Board members.
Copyright Policy
By submitting a manuscript to AJCR, all authors agree that all copyrights of all materials included in the submitted
manuscript will be exclusively transferred to the publisher - e-Century Publishing Corporation once the manuscript is
accepted.
Once the paper is published, the copyright will be released by the publisher under the “Creative Commons Attribution
Noncommercial License”, enabling the unrestricted non-commercial use, distribution, and reproduction of the published
article in any medium, provided that the original work is properly cited. If the manuscript contains a figure or table
reproduced from a book or another journal article, the authors should obtain permission from the copyright holder before
submitting the manuscript, and be fully responsible for any legal and/or financial consequences if such permissions are not
obtained.
All PDF, XML and html files for all articles published in this journal are the property of the publisher, e-Century Publishing
Corporation (www.e-Century.org). Authors and readers are granted the right to freely use these files for all academic
purposes. By publishing paper in this journal, the authors grant the permanent right to the publisher to use any articles
published in this journal without any restriction including, but not limited to academic and/or commercial purposes. If you
are interested in using PDF, html, XML files or any art works published in this journal for any commercial purposes, please
contact the publisher at business@e-century.org.
Use of Human Subjects/Human Tissue and/or Animal Policy
Experiments involving human subjects should be done in accordance with the relevant ethical and legal standards
established and accepted by their host institution or in accordance with the Helsinki Declaration of 1975, or the Guidelines
of Office for Human Research Protections (OHRP) Human Subject Protections or equivalent. For studies that involved
human subjects, when informed consent has been obtained it should be indicated in the manuscript.
Experiments involving animals should follow the appropriate institution or the National Research Council Guide for the care
and use of laboratory animals.
Units and Abbreviations
System International (SI) units should be used for all measurements. All abbreviations should be explicitly defined at their
first occurrence except for those internationally acceptable. Abbreviations used in the genetic association reports will need
to follow the conventions detailed in the specific information requirements for genetic association reports. Any articles that
involve the description of enzymes will require the inclusion of the appropriate EC (Enzyme Commission) number as
recommended by the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (IUBMB).
Disclaimer
While the advice and information in the article are believed to be true and accurate on the date of its going to press, neither
the authors nor the editors can accept any legal responsibilities for any errors or omissions that may be made. The
publication makes no warranty, expressed or implied, with respect to the materials contained within.
PREPARATION OF MANUSCRIPT (Click to submit a manuscript)
All manuscripts should be written in standard grammatical English using computer software (Franklin Gothic Book normal
font, size 12, with single spacing between lines) and should be saved as single DOC (Word) file. Main Research Articles
and Brief Communications will follow a similar format as outlined below while Review Articles will follow a variation on this
(see below).
Main Research Articles are defined as being a substantial novel research study discussing the investigation of a clear
hypothesis or research question with appropriate methodologies (the use of more than one approach is encouraged) and
adequately powered studies and sample sizes. Noting the relevant sections (see below) there is no word limit on
manuscripts of this type except for the Abstract which should be a single unreferenced paragraph and no more than 350
words. There are no limits on the number of display items (tables and/or figures) although authors should try to be concise
and only include the most pertinent information. There are no supplementary tables or figures and every effort should be
made to include these in the main manuscript or alternatively reference should be made in the appropriate locations of the
manuscripts that such information will be available on request from the corresponding authors. There is no limit on the
number of references.
Brief Communications are a format that accommodates the reporting of high quality completed smaller scale studies yet
with important findings. This format is not for the reporting of preliminary or incomplete findings and the review process is
equally rigorous as that for Main Articles. The sections of a Brief Communication follow those of Main Articles (see below)
and there should not be additional sub-headings within these sections.
Review articles have a flexible format, are not of restricted length or reference number. Submissions of reviews must follow
that of Main Research Articles (see below) with the exception that appropriate headings be included for the main text of the
manuscript.
Layout requirements for submissions of Main Research Articles or Brief Communications:
1. cover letter
2. title page
3. abstract and keywords
4. main text
5. acknowledgements, if any
6. Declaration of conflicts of interest, if any
7. References
8. tables, if any
9. figure legends, if any
10. figures, if any
Cover Letter
The cover letter should include name, degree, address, telephone, fax and email of the corresponding author. A statement
that all authors have contributed to, read and approved the final manuscript for submission should be included if there are
multiple authors. Any editorial or financial conflict of interest (e.g., consultancy, stock ownership, equity interests, patent or
licensing agreements) should be clearly disclosed in the cover letter. The disclosure statement must be submitted upon
the acceptance. The cover letter should also be used to provide up the relevant details of 4 potential reviewers and 2 non-
reviewers for your manuscript giving appropriate explanations for the latter. Finally, if this submission is following the
solicitation or invitation of an Editorial Board member please state by whom.
Title Page
1. a concise title;
2. first name, middle initial, and last name of each author;
3. name of the department and institutional affiliation of each author.
4. the email address of each author.(*)
5. a running title.
(*) AJCR will only use the email address of the designated corresponding author in the final published manuscript but will
use all email addresses supplied to copy in all authors as additional email respondents to the correspondences we routinely
send to acknowledge receipt of manuscripts, and final decisions made on submitted manuscripts. AJCR would also like,
unless otherwise directed in the manuscript covering letter, to use these contact details to announce the contents lists of
future issues of AJCR and its sister journals! At no stage will AJCR sell such email lists to parties external to the e-Century
Publishing Corporation.
Abstract and Key Words
The abstract should not exceed 350 words that concisely summarize the study’s purpose, significant findings and
conclusions. Include up to 10 key words or phrases at the end of the abstract.
Main Text
The main text should include Introduction, Materials and Methods, Results and Discussion. The Introduction should be
succinct, clearly stating the purpose and rationale of the study. In Materials and Methods, the procedures should be
described in sufficient detail to allow duplication by an independent observer. Results and Discussion should be divided.
They should be written concisely and logically with emphasis on novel findings and minimal repetition of text. For genetic
association reports refer to specific information requirements.
Acknowledgements
All acknowledgements (if any) should be included at the end of the main text before references and may include grant and
administrative support.
References (Please download EndNote X Style or Reference Manager Output Style for AJCR)
Reference published in AJCR should begin on a new page, be single-spaced and numbered in order of citation in the text,
including citations in tables and figure legends. Complete author citation is required (use of "et al" is not acceptable).
References should conform to the style of the Journal. Examples follow:
Journals: [1] Yin M, Hu Z, Tan D, Ajani JA, Wei Q. Molecular epidemiology of genetic susceptibility to gastric cancer: focus on
single nucleotide polymorphisms in gastric carcinogenesis. Am J Transl Res 2009;1:44-54.
Books: Fishman AP: Pulmonary Hypertension and Cor Pulmonale. Pulmonary Diseases and Disorders. Edited by Fishman
AP. New York, McGraw-Hill, 1988, pp. 999-1048
Web sites: Cite in text only using the appropriate URL. It is the authors responsibility at the time of submission and
subsequent publication that the website address is relevant and functional.
In press: To be used only for papers accepted for publication. Cite as for journal with (in press) in place of volume and page
numbers.
Personal Communications: to be used very sparingly and in the context of no more than one sentence of associated text.
Submitted papers/unpublished data: Cite in text only.
Tables
All tables should be created with Microsoft Word Insert Table Tool, single spacing between rows and cited consecutively in
the main text by Arabic numbers (Table 1, Table 2, etc). Include each table with a descriptive title on a separate page after
the references. Provide explanations for any nonstandard abbreviations in footnotes to the table.
All tables should be included in the Word File as the part of the complete manuscript after bibliography. Tables in image or
other formats are not acceptable. Authors are encouraged to split extremely large tables into multiple smaller ones to
facilitate publication and easiness to readers.
Figure Legends
Figure legends including figure number, a short title and detailed description should be embedded at the end of text file.
Figures
All figures should be cited consecutively in the main text by Arabic numbers (Figure 1, Figure 2, etc). All figures in high quality
must be insert at the end of the Word File of the manuscript and labeled with the corresponding numbers. Photographs of a
person should render them unidentifiable or include their written permission. Any figures involving Copyright issues should
conform to the Copyright policy.
Publication Fees
American Journal of Cancer Research is an open access journal which provides instant, worldwide and barrier-free access
to the full-text of all published articles. Publication charges allow the publisher to make the published material available for
free to all interested online readers.
The Open Access publication fee is $1380 per article. This will be billed to the corresponding author if the manuscript is
accepted. There is no extra charge for any number of tables or color figures.
Manuscript Submission
The journal invites submission of all original research and review articles, editorials, letter to the editor and meeting reports.
AJCR will also consider methodological articles. All manuscripts should be submitted via email to: editorial@AJCR.us and
should be in compliance with the author’s guidelines described above. Please visit submission for further information then
click to submit your manuscript online.
Editorial Board
Editorial Board Policy: AJCR welcomes all qualified researchers and physicians who are interested in joining this effort of promoting
open access to medical scholarly journals join the editorial board. Please read the Editorial Board Policy and contact us if you are
interested.
Editor-in-Chief
Joseph H. Antin, MD,
Dana-Farber Cancer Institute Harvard Medical School
Boston, MA, USA
Associate Editor-in-Chief
Vincent L. Cryns, MD
University of Wisconsin
Madison, USA
Associate Editor-in-Chief
Sheue-yann Cheng, PhD,
National Cancer Institute
Bethesda, MD, USA
Associate Editor-in-Chief
Michael R. Emmert-Buck, MD, PhD
National Cancer Institute
Bathesda, MD, USA
Associate Editor-in-Chief
Andrew E. Aplin, PhD,
Thomas Jefferson University
Philadelphia, PA, USA
Associate Editor-in-Chief
Dengshun Wang, MD, PhD
University of Wisconsin
Madison, WI, USA
Founding Editorial Board (in alphabetical order) (Editorial Board Policy)
Bharat B. Aggarwal, PhD,The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
David D. Bowtell, PhD, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia
Ting-Chao Chou, PhD, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
James J Goedert, MD, National Cancer Institute, Bethesda, MD, USA
Mien-Chie Hung, PhD, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Roy A Jensen, MD, University of Kansas Cancer Center, Kansas City, KS, USA
Guido Kroemer, MD, PhD, University Paris 5 Rene Descartes, Paris, France
Christopher J Logothetis, MD, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Lucio Miele, MD, PhD, Cancer Institute, the University of Mississippi Medical Center, Jackson, MS, USA
Stephen Safe, PhD, Center for Environmental & Genetic Medicine, Texas A&M Health Science Center, College Station, TX, USA
Michael J Seckl, PhD, Molecular Cancer Medicine and Lung Cancer Biology, Imperial College London, London, UK
Dietmar W Siemann, PhD, University of Florida Shands Cancer Center, Gainesville, FL, USA
Anil K Sood, MD, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Joseph R Testa, PhD, Fox Chase Cancer Center, Philadelphia, PA, USA
Axel Ullrich, PhD, Max Planck Institute of Biochemistry, Martinsried, Germany
|
